Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 15.08 is 100% above its 5-year average of 7.53, around the middle of its 5-year range (1.51–21.68).
As of the fiscal period ended Tuesday, June 30, 2026. 4.02% above its 12-month average of 14.49.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.08.
QUICK RATIO (ACID-TEST)
15.08
QUICK RATIO (ACID-TEST) AVG TTM
14.49
QUICK RATIO (ACID-TEST) AVG 3Y
8.41
QUICK RATIO (ACID-TEST) AVG 5Y
7.53
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.02%
CURRENT VS 3Y AVG
+79.25%
CURRENT VS 5Y AVG
+100.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+349.39%
vs the sector median at left
Immunome, Inc.
Market Cap
$1.85B
Quick Ratio (Acid-Test)
15.08
TTM Avg
14.49
3Y Avg
8.41
5Y Avg
7.53
Market Cap
$1.84B
Quick Ratio (Acid-Test)
21.18
TTM Avg
6.27
3Y Avg
4.65
5Y Avg
4.09
Market Cap
$1.83B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.57
3Y Avg
2.04
5Y Avg
2.44
Market Cap
$1.83B
Quick Ratio (Acid-Test)
2.62
TTM Avg
2.33
3Y Avg
2.98
5Y Avg
3.78
Market Cap
$1.87B
Quick Ratio (Acid-Test)
37.28
TTM Avg
15.04
3Y Avg
13.56
5Y Avg
10.93
Market Cap
$1.81B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.85B | 15.08 | 14.49 | 8.41 | 7.53 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 21.18 | 6.27 | 4.65 | 4.09 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
| Novavax, Inc. (NVAX)vs › | $1.86B | 2.30 | 1.54 | 1.10 | 1.25 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | 2.62 | 2.33 | 2.98 | 3.78 |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 37.28 | 15.04 | 13.56 | 10.93 |
| Azenta, Inc. (AZTA)vs › | $1.81B | 2.21 | 3.08 | 5.65 | 4.53 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 13.96 | 11.13 | 7.91 | 6.39 |
| Xencor, Inc. (XNCR)vs › | $1.81B | 6.39 | 6.43 | 7.70 | 7.01 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 7.14 | 4.14 | 3.11 | 3.56 |
Quick Ratio
15.08
Excludes inventory
Current Ratio
15.08
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 15.08 |
| 2026-03-31 | 21.68 |
| 2025-12-31 | 14.69 |
| 2025-09-30 | 8.90 |
| 2025-06-30 | 12.13 |
| 2025-03-31 | 10.49 |
| 2024-12-31 | 4.08 |
| 2024-09-30 | 6.17 |
| 2024-06-30 | 7.12 |
| 2024-03-31 | 10.18 |
| 2023-12-31 | 6.63 |
| 2023-09-30 | 3.96 |
| 2023-06-30 | 1.51 |
| 2023-03-31 | 1.91 |
| 2022-12-31 | 3.09 |
| 2022-09-30 | 3.97 |
| 2022-06-30 | 4.36 |
| 2022-03-31 | 4.77 |
| 2021-12-31 | 5.82 |
| 2021-09-30 | 7.88 |
| 2021-06-30 | 17.84 |
| 2021-03-31 | 8.99 |
| 2020-12-31 | 14.40 |
| 2020-09-30 | 1.38 |
| 2020-06-30 | 3.65 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.88 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
